Clincosm LogoSign in Get a demo

Refractory Plasma Cell Myeloma

Showing 51 - 75 of 80
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Indianapolis, Rochester, Wauwatosa (Bortezomib,

Withdrawn
  • Recurrent Plasma Cell Myeloma
  • Refractory Plasma Cell Myeloma
  • Indianapolis, Indiana
  • +2 more
Sep 29, 2020

DS Stage I Plasma Cell Myeloma, DS Stage II Plasma Cell Myeloma, DS Stage III Plasma Cell Myeloma Trial in Jacksonville,

Completed
Has Results
  • DS Stage I Plasma Cell Myeloma
  • +3 more
  • Autologous Bone Marrow Transplantation
  • +4 more
  • Jacksonville, Florida
  • +1 more
Aug 18, 2020

DS Stage I Plasma Cell Myeloma, DS Stage II Plasma Cell Myeloma, DS Stage III Plasma Cell Myeloma Trial in New Brunswick, Bronx,

Completed
Has Results
  • DS Stage I Plasma Cell Myeloma
  • +3 more
  • New Brunswick, New Jersey
  • +3 more
Aug 11, 2020

HLA-A*0201 Positive Cells Present, NY-ESO-1 Positive Tumor Cells Present, Recurrent Plasma Cell Myeloma Trial in Los Angeles

Withdrawn
  • HLA-A*0201 Positive Cells Present
  • +3 more
  • 18F-FHBG
  • +10 more
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
Jul 22, 2020

Advanced Lymphoma, Advanced Malignant Solid Tumor, Hematopoietic and Lymphoid Cell Tumor Trial in Philadelphia (Dasatinib)

Withdrawn
  • Advanced Lymphoma
  • +5 more
  • Philadelphia, Pennsylvania
    ECOG-ACRIN Cancer Research Group
Jul 17, 2020

Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in United States (Carfilzomib, Dexamethasone, Laboratory

Completed
Has Results
  • Recurrent Plasma Cell Myeloma
  • Refractory Plasma Cell Myeloma
  • Fairbanks, Alaska
  • +484 more
Apr 3, 2020

Hematopoietic Cell Transplantation Recipient, Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Columbus

Withdrawn
  • Hematopoietic Cell Transplantation Recipient
  • +2 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Feb 19, 2020

Refractory Plasma Cell Myeloma Trial in Seattle (procedure, drug, other, radiation)

Completed
Has Results
  • Refractory Plasma Cell Myeloma
  • Autologous Hematopoietic Stem Cell Transplantation
  • +10 more
  • Seattle, Washington
    Fred Hutchinson Cancer Research Center/University of Washington
Jan 13, 2020

DS Stage I Plasma Cell Myeloma, DS Stage II Plasma Cell Myeloma, DS Stage III Plasma Cell Myeloma Trial in Bronx (drug,

Completed
  • DS Stage I Plasma Cell Myeloma
  • +3 more
  • Desipramine Hydrochloride
  • +2 more
  • Bronx, New York
    Albert Einstein College of Medicine
Dec 10, 2019

Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Seattle (procedure, drug, radiation)

Completed
  • Plasma Cell Myeloma
  • Refractory Plasma Cell Myeloma
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +6 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Dec 6, 2019

DS Stage I Plasma Cell Myeloma, DS Stage II Plasma Cell Myeloma, DS Stage III Plasma Cell Myeloma Trial in Seattle

Completed
Has Results
  • DS Stage I Plasma Cell Myeloma
  • +3 more
  • Seattle, Washington
    Fred Hutchinson Cancer Research Center/University of Washington
Oct 29, 2019

Myelodysplastic/Myeloproliferative Tumor, Unclassifiable, Previously Treated Myelodysplastic Syndrome, Refractory Chronic

Completed
Has Results
  • Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable
  • +115 more
  • Fludarabine Phosphate
  • +6 more
  • Denver, Colorado
  • +10 more
Oct 29, 2019

Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Scottsdale, Jacksonville, Rochester (Cyclophosphamide,

Completed
Has Results
  • Recurrent Plasma Cell Myeloma
  • Refractory Plasma Cell Myeloma
  • Scottsdale, Arizona
  • +2 more
Aug 29, 2019

Plasma Cell Leukemia, Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Houston (Carfilzomib, Filanesib,

Completed
  • Plasma Cell Leukemia
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Jul 12, 2019

B-Cell Prolymphocytic Leukemia, Hypodiploidy, Loss of Chromosome 17p Trial in Seattle, Milwaukee (procedure, drug, other,

Completed
Has Results
  • B-Cell Prolymphocytic Leukemia
  • +20 more
  • Allogeneic Bone Marrow Transplantation
  • +14 more
  • Seattle, Washington
  • +1 more
May 31, 2019

Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Columbus (other, drug, biological)

Terminated
Has Results
  • Recurrent Plasma Cell Myeloma
  • Refractory Plasma Cell Myeloma
  • Laboratory Biomarker Analysis
  • +3 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
May 29, 2019

Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma, t(11;14) Negative Trial (Dexamethasone, Ixazomib, Ixazomib

Withdrawn
  • Recurrent Plasma Cell Myeloma
  • +2 more
  • (no location specified)
Mar 25, 2019

Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Rochester (Dexamethasone, Lenalidomide, Pomalidomide)

Completed
Has Results
  • Recurrent Plasma Cell Myeloma
  • Refractory Plasma Cell Myeloma
  • Rochester, Minnesota
    Mayo Clinic
Aug 14, 2018

Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Winston-Salem (Laboratory Biomarker Analysis,

Withdrawn
  • Recurrent Plasma Cell Myeloma
  • Refractory Plasma Cell Myeloma
  • Laboratory Biomarker Analysis
  • +2 more
  • Winston-Salem, North Carolina
    Comprehensive Cancer Center of Wake Forest University
Jun 29, 2018

DS Stage I Plasma Cell Myeloma, DS Stage II Plasma Cell Myeloma, DS Stage III Plasma Cell Myeloma Trial in Rochester (drug,

Completed
  • DS Stage I Plasma Cell Myeloma
  • +3 more
  • Rochester, Minnesota
    Mayo Clinic
May 23, 2018

Refractory Plasma Cell Myeloma Trial in Scottsdale (Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Laboratory Biomarker

Terminated
Has Results
  • Refractory Plasma Cell Myeloma
  • Paclitaxel Albumin-Stabilized Nanoparticle Formulation
  • Laboratory Biomarker Analysis
  • Scottsdale, Arizona
    Mayo Clinic in Arizona
Sep 14, 2017

DS Stage I Plasma Cell Myeloma, DS Stage II Plasma Cell Myeloma, DS Stage III Plasma Cell Myeloma Trial in Tampa (procedure,

Withdrawn
  • DS Stage I Plasma Cell Myeloma
  • +3 more
  • Autologous Hematopoietic Stem Cell Transplantation
  • +5 more
  • Tampa, Florida
    Moffitt Cancer Center
Sep 27, 2017

Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Portland (Cyclophosphamide, Dexamethasone,

Completed
  • Recurrent Plasma Cell Myeloma
  • Refractory Plasma Cell Myeloma
  • Portland, Oregon
    OHSU Knight Cancer Institute
Sep 5, 2017

Adult B Acute Lymphoblastic Leukemia, Chronic Lymphocytic Leukemia, Cutaneous B-Cell Non-Hodgkin Lymphoma Trial in United States

Terminated
  • Adult B Acute Lymphoblastic Leukemia
  • +28 more
  • Los Angeles, California
  • +6 more
Aug 18, 2015

Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in United States (Laboratory Biomarker Analysis,

Completed
Has Results
  • Recurrent Plasma Cell Myeloma
  • Refractory Plasma Cell Myeloma
  • Tampa, Florida
  • +8 more
Jul 24, 2015